Co-Diagnostics, Inc. Quarterly Operating Lease, Right-of-Use Asset in USD from Q1 2022 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Co-Diagnostics, Inc. quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q1 2022 to Q3 2024.
  • Co-Diagnostics, Inc. Operating Lease, Right-of-Use Asset for the quarter ending September 30, 2024 was $2.33M, a 23.1% decline year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 $2.33M -$699K -23.1% Sep 30, 2024 10-Q 2024-11-07
Q2 2024 $2.55M -$681K -21.1% Jun 30, 2024 10-Q 2024-08-08
Q1 2024 $2.76M +$1.81M +190% Mar 31, 2024 10-Q 2024-05-09
Q4 2023 $2.97M +$2.59M +697% Dec 31, 2023 10-Q 2024-11-07
Q3 2023 $3.03M +$2.58M +565% Sep 30, 2023 10-Q 2023-11-09
Q2 2023 $3.23M +$2.7M +509% Jun 30, 2023 10-Q 2023-08-10
Q1 2023 $952K +$347K +57.4% Mar 31, 2023 10-Q 2023-05-11
Q4 2022 $372K Dec 31, 2022 10-K 2024-03-14
Q3 2022 $456K Sep 30, 2022 10-Q 2022-11-10
Q2 2022 $530K Jun 30, 2022 10-Q 2022-08-11
Q1 2022 $605K Mar 31, 2022 10-Q 2022-05-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.